[Cormorbidity in multiple sclerosis and its therapeutic approach].
Multiple sclerosis (MS) is a long-term chronic disease, in which intercurrent processes develop three times more frequently in affected individuals than in persons without MS. Knowledge of the comorbidity of MS, its definition and measurement (Charlson index) improves patient management. Acting on comorbid conditions delays the progression of disability, which is intimately linked to the number of concurrent processes and with health states and habits. Moreover, the presence of comorbidities delays the diagnosis of MS, which in turn delays the start of treatment. The main comorbidity found in MS includes other autoimmune diseases (thyroiditis, systemic lupus erythematosus, or pemphigus) but can also include general diseases, such as asthma or osteomuscular alterations, and, in particular, psychiatric disturbances. All these alterations should be evaluated with multidimensional scales (Disability Expectancy Table, DET), which allow more accurate determination of the patient's real clinical course and quality of life. These scales also allow identification of how MS, concurrent and intercurrent processes occurring during the clinical course, and the treatment provided affect patients with MS. An overall approach to patients' health status helps to improve quality of life.
Unitat d'Esclerosi Múltiple, Hospital Universitari i Politècnic La Fe, València, España. Electronic address: casanova.bonaventura@gmail.com.
Bonaventura Casanova
BC
Estruch
D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications* / Q000628:therapy*
Comorbidity; Comorbilidad; Esclerosis múltiple; Health habits; Hábitos de salud; Multiple sclerosis